INTERVIEW: Johnson & Johnson Innovation's J-Labs seeks out new ideas in Texas
This article was originally published in Scrip
Executive Summary
Johnson & Johnson has long been an investor in early stage science, and the company is increasing its geographic reach with the launch of a new J-Labs incubator in Houston, Texas. The incubator is part of its J-Labs offering, formerly known as Janssen Labs, and will be housed within the Texas Medical Center's new Innovation Institute. Called J-Labs @TMC, it will be home to up to 50 start-ups that could come from any areas that J&J is involved in: namely, consumer, medical devices/diagnostics, and pharma.
You may also be interested in...
J&J's Longtime R&D Head Stoffels To Retire, Raising The Leadership Transition Stakes
Chief scientific officer Paul Stoffels will retire at the end of the year at the same time CEO Alex Gorsky will hand over the top leadership role to Joaquin Duato; no successor has been named.
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.